How Cvent is Leveraging Data to Power Event Management
Capturing and understanding data is becoming increasingly important for business. Software company Cvent is working to help businesses better understand how attendees are responding to their events. Cvent's Chief Marketing Officer Patrick Smith explains how its technology works for both event planners and venues.
Smith says Cvent's technology powers the human connection, and sits at the intersection of event planners, venues, and hosts. The Cvent platform offers features such as online registration and attendee tracking. Smith says the technology ultimately automates the process.
In 2017, Cvent was acquired by Vista Equity Partners for $1.65 Billion. "They've done a great job investing in the business, and helping us accelerate our growth plans around the world," said Smith.
Merriam-Webster has fully revised its popular “Collegiate” dictionary with over 5,000 new words. They include “petrichor,” “dumbphone” and “ghost kitchen.” Also “cold brew,” “rizz,” “dad bod,” “hard pass,” “cancel culture” and more.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
